QIMR Berghofer scientists have discovered a cancer-fighting RNA molecule that could hold the key to a new way of treating the ...

This biography of the 1962 Nobel Prize-winning scientist reveals a mighty intellect who loved the arts as much as science.

Acurx Pharmaceuticals’ DNA Polymerase IIIC inhibitors receives US patent: Staten Island, New York Wednesday, February 4, 2026, 15:00 Hrs [IST] Acurx Pharmaceuticals, Inc., a lat ...

Scientists have uncovered a surprising genetic shift that may explain how animals with backbones—from fish and frogs to ...

DNA's iconic double helix does more than "just" store genetic information. Under certain conditions it can temporarily fold into unusual shapes. Researchers at Umeå University, Sweden, have now shown ...

IPA, a non-coding RNA from the CUL1 gene that stabilizes the nucleolus and supports ribosome production. Removing it ...

Life on Earth may have started with a molecule that still runs our cells today. As researchers probe ribonucleic acid in the lab and in ancient rocks and space dust, RNA is yielding clues that are far ...

Dr. Kennedy joins Aprea at an important time, following the Company’s recent early clinical proof-of-concept demonstrated in its ongoing Phase 1 dose-escalation study evaluating the WEE1 inhibitor APR ...

This local biotech says it has found a way to trick cancer cells into destroying themselves with its molecular glue. Now it’s putting that claim to the test. After attracting global attention from ...

“Our participation in Boston transformed our standing from a quiet innovator to a recognized problem-solver in the DDR space,” added Prof. Daugaard. “We have confirmed that our scientific rationale is ...

The Flagship Pioneering spinout uses permanent bonds to target shallow pockets, drastically expanding the druggable universe for small molecules.

Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...